Sex Cord-Stromal Tumor — Trials

Sex Cord-Stromal Tumor — Trials · CancerIndex

Clinical trials

Registered studies

25 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–14 of 14 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03866382	Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors	recruiting	Phase 2	314	National Cancer Institute (NCI)NIH	2	Sep 29, 2026	clinicaltrials
NCT05348356	Nirogacestat in Ovarian Granulosa Cell Tumors	completed	Phase 2	53	SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyINDUSTRY	3	Aug 25, 2026	clinicaltrials
NCT06169124	Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors	active not recruiting	Phase 2	17	National Cancer Institute (NCI)NIH	1	Jul 28, 2026	clinicaltrials

Data updated 18 hours agoSource updated Sep 29, 2026source: clinicaltrials